Bharat Biotech Says 'No Wrongdoing' Amid Row Over Brazil Covaxin Deal

  • 3:32
  • Published On: June 30, 2021
Cinema View
Embed
Bharat Biotech today emphatically denied any wrongdoing amid a huge controversy in Brazil over a $324 million contract for Covaxin shots, now suspended over allegations of irregularities. In a statement, Bharat Biotech said it had followed a "step-by-step" approach towards contracts and regulatory approvals with Brazil.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
August 22, 2023 1:33
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
April 22, 2023 1:07
Bharat Biotech's Suchitra Ella On The Lessons From The Covid-19 Pandemic
April 14, 2023 8:47
World's 1st Covid Nasal Vaccine Out On Republic Day
January 26, 2023 8:39
India Gets Its Own Nasal Vaccine, Booster Costs Rs. 800 Per Dose
January 26, 2023 1:18
"Isolated Events Can't Dent India's Image": Adar Poonawalla To NDTV
January 17, 2023 2:05
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination